4//SEC Filing
Sakiris Spiro Kevin 4
Accession 0001493152-24-010846
CIK 0001725430other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 7:55 PM ET
Size
9.2 KB
Accession
0001493152-24-010846
Insider Transaction Report
Form 4
Sakiris Spiro Kevin
Chief Financial Officer
Transactions
- Exercise of In-Money
Common Stock
2024-03-20+9,394→ 19,180 total(indirect: Held by Anest Holdings Pty Ltd) - Exercise of In-Money
Common Stock Warrants (Series F)
2024-03-20−9,394→ 0 total(indirect: Held by Anest Holdings Pty Ltd)Exp: 2025-04-04→ Common Stock (9,394 underlying)
Holdings
- 314
Common Stock
Footnotes (4)
- [F1]The number of reported securities has been adjusted in order to reflect a 1-for-12 reverse stock split effected on January 26, 2024 (the "Reverse Stock Split").
- [F2]The Series F Warrants have an exercise price is $6.60 per share (after Reverse Stock Split related adjustments) and are also exercisable pursuant to an alternate cashless exercise formula set forth in the warrant. The Series F Warrants in the reported transaction were exercised pursuant to the alternate cashless exercise formula for an equal number of shares of common stock on a one-for-one basis, without payment of additional consideration therefore.
- [F3]The Series F Warrants became exercisable on November 17, 2023, the date the Issuer's stockholders approved, for purposes of complying with Nasdaq Listing Rules 5635(c) and (d), the issuance of the shares underlying the Series F Warrants.
- [F4]These securities are held by Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, of which Mr. Sakiris is a director.
Documents
Issuer
INTELLIGENT BIO SOLUTIONS INC.
CIK 0001725430
Entity typeother
Related Parties
1- filerCIK 0001830957
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 7:55 PM ET
- Size
- 9.2 KB